Increasing evidence from recent studies showed that the transcription factor NF-E2-related factor 2 (Nrf2) plays a critical role in promoting cancer recurrence through increased tolerance to adjuvant chemo- and/or radiation therapies. This evidence concerns the gene NFE2L2 and cancer.